The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
Phones:
+7 (495) 482-4118
+7 (495) 482-4329
  • Toll-free number for subscriptions:
    +8 800 250-18-12
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Goryunova A.V.

Russian Medical Academy for Continuous Professional Education

Shevchenko Yu.S.

Russian Medical Academy of Advanced Professional Education

Goryunov A.V.

Mental Health Research Center

Cogitum in children’s neurology and psychiatry (experience in the practical use)

Authors:

Goryunova A.V., Shevchenko Yu.S., Goryunov A.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(7‑2): 58‑66

DOI: 10.17116/jnevro201911907258

Read: 299750 times

Contact the author
Table of contents

COGITUM IN CHILDREN’S NEUROLOGY AND PSYCHIATRY (EXPERIENCE IN THE PRACTICAL USE)
COGITUM IN CHILDREN’S NEUROLOGY AND PSYCHIATRY (EXPERIENCE IN THE PRACTICAL USE)

To cite this article:

Goryunova AV, Shevchenko YuS, Goryunov AV. Cogitum in children’s neurology and psychiatry (experience in the practical use). S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(7‑2):58‑66. (In Russ.)
https://doi.org/10.17116/jnevro201911907258

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Cogi­tum in the treatment of mental diso­rders in childhood. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10-2):88-95
Psychosomatic sets of symptoms in schi­zotypal personality diso­rder. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):46-54
Mito­chondrial cyto­protectors in complex therapy of chro­nic heart failure in patients with meta­bolic syndrome or type 2 diabetes mellitus: suba­nalysis of the INDI­KOR study. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(5):566-576
Resu­lts of the obse­rvational program CITO­TREK (use of the drug CITO­flavin in Tablets) in patients with tension headaches against the backgRound of asthenic syndromE taKing into account como­rbidity. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10):104-112
Search for neurophysiological markers of schi­zophrenia spectrum diso­rders: ocular microtremor and contrast sensitivity. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12):228-236
Atte­ntion defi­cit diso­rder in adults: features of social and family rela­tionships. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;(1):13-18
The rela­tionship between the aspe­cts of mindfulness and coping stra­tegies in patients with schi­zophrenic spectrum diso­rders and anorexia nervosa. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;(1):61-68
Analysis of therapy for schi­zotypal diso­rder with onset in childhood and adolescence at the acute and maintenance stages: resu­lts of a retrospective obse­rvational study. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;(4):81-88
Cognitive impairment after COVID-associated pneumonia: resu­lts of a prospective cohort study of risk factors. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;(5):43-47
Correction of auto­nomic nervous system diso­rders: resu­lts from an obse­rvational study. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;(5):57-62
Abstract:

The authors review current data on the role of the synthetic aspartic acid analogue N-acetyaspartate (NAA) in various biochemical metabolic reactions in the CNS. Its importance as a biomarker for neuropsychiatric disorders identified using magnetic resonance spectroscopy (MRS) is noted. The authors present their own results of the use of cogitum, a synthetic analogue of NAA, in children with the effects of traumatic brain injury, mental retardation, hyperactivity disorder and in the complex therapy of schizotypal disorder. Effects of cogitum on cognitive deficit, asthenia are evaluated. The neurotrophic effect of the drug, which specifically affects cognitive and asthenic disorders in these diseases, is shown.

Keywords:

cogitum
N-acetylaspartate
cognitive deficit
asthenia
impaired mental function
hyperactivity disorder
schizotypical disorder

Authors:

Goryunova A.V.

Russian Medical Academy for Continuous Professional Education

Shevchenko Yu.S.

Russian Medical Academy of Advanced Professional Education

Goryunov A.V.

Mental Health Research Center

Close metadata

References:

  1. Tallan HH, Moore S, Stein WH. N-Acetyl-L-aspartic acid in brain. J Biol Chem. 1956;219:257-264.
  2. Bluml S, Moreno-Torres A, Shic F, Nguy CH, Ross BD. Tricarboxylic acid cycle of glia in the in vivo human brain. NMR Biomed. 2002;15:1-5. https://doi.org/10.1006/jmre.1998.1618
  3. Pan JW, Takahashi K. Interdependence of N-acetyl aspartate and high-energy phosphates in healthy human brain. Ann Neurol. 2005;57:92-97. https://doi.org/10.1002/ana.20317
  4. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM. N-Acetylaspartate in the CNS: fron neurodiagnostics to neurobiology Prog Neurobiol. 2007;81:(2):89-131. https://doi.org/10.1016/j.pneurobio.2006.12.003
  5. Baslow MH, Suckow R, Sapirstein V, Hungund BL. Expression of aspartoacylase activity in cultured rat macroglial cells is limited to oligodendrocytes. J Mol Neurosci. 1999;13:47-53. https://doi.org/10.1385/JMN:13:1-2:47
  6. Martinchik AN, Maev KB, Yanushevich OO. Obshchaya nutriciologiya. Uchebnoe posobie. M.: MEDpress-inform; 2005. (In Russ.)
  7. Baslow MH. Functions of N-acetyl-L-aspartate and N-Acetyl-L-aspartylglutamate in the vertebrate brain: role in glial cell-specific signaling. Journal of Neurochemistry. 2000;75(2):453-459. https://doi.org/10.1046/j.1471-4159.2000.0750453.x
  8. Baslow MH. Evidence supporting a role for N-acetyl-L-aspartate as a molecular water pump in myelinated neurons in the central nervous system. An analytical review. Neurochem Int. 2002;40(4):295-300. https://doi.org/10.1016/s0197-0186(01)00095-x
  9. Tavazzi B, Lazzarino G, Leone P, Amorini AM, Bellia F, Janson CG, Di Pietro V, Ceccarelli L, Donzelli S, Francis JS, Giardina B: Simultaneous high performance liquid chromatographic separation of purines, pyrimidines, N-acetylated amino acids, and dicarboxylic acids for the chemical diagnosis of inborn errors of metabolism. Clin Biochem. 2005;38(11):997-1008. PubMed:16139832.
  10. Berger UV, Luthi-Carter R, Passani LA, Elkabes S, Black I, Konradi C, Coyle JT. Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system. Journal of Comparative Neurology. 415:1:52-64. https://doi.org/10.1002/(SICI)1096-9861(19991206)415:1<52::AID-CNE4>3.0.CO;2-K
  11. Matalon R, Michals K, Sebesta D, Deanching M, Gashkoff P, Casanova J. Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease. Am J Med Genet. 1988;29(2):463-471. PubMed:3354621 https://doi.org/10.1002/ajmg.1320290234
  12. Luyten PR, den Hollander JA. Observation of metabolites in the human brain by MR spectroscopy. Radiology. 1986;161:795-798. https://doi.org/10.1148/radiology.161.3.3786735
  13. Fan TW, Higashi RM, Lane AN, Jardetzky O. Combined use of 1H-NMR and GC-MS for metabolite monitoring and in vivo 1H-NMR assignments. Biochim Biophys Acta. 1986;882:154-167. https://doi.org/10.1016/0304-4165(86)90150-9
  14. Barany M, Spigos DG, Mok E, Venkatasubramanian PN, Wilbur AC, Langer BG. High resolution proton magnetic resonance spectroscopy of human brain and liver. Magn Reson Imaging. 1987;5:393-398. https://doi.org/10.1016/0730-725X(87)90128-7
  15. Wild JM, Wardlaw JM, Marshall I, Warlow CP. N-acetylaspartate distribution in proton spectroscopic images of ischemic stroke: relationship to infarct appearance on T2-weighted magnetic resonance imaging. Stroke. 2000;31:1524-4628. http://www.biomedsearch.com/nih/N-acetylaspartate- distribution-in-proton/11108764.html
  16. Barker PB, Lin D. In vivo proton MR spectroscopy of the human brain. Progress in Nuclear Magnetic Resonance Spectroscopy. 2006;49(2):99-128. https://doi.org/10.1016/j.pnmrs.2006.06.002
  17. Parsons MW, Li T, Barber PA, Yang Q, Darby DG, Desmond PM, Gerraty RP, Tress BM, Davis SM. Combined (1)H MR spectroscopy and diffusion-weighted MRI improves the prediction of stroke outcome. Neurology. 2000;55:498-505. https://doi.org/10.1212/WNL.55.4.498
  18. Wild JM, Wardlaw JM, Marshall I, Warlow CP. N-acetylaspartate distribution in proton spectroscopic images of ischemic stroke: relationship to infarct appearance on T2-weighted magnetic resonance imaging. Stroke. 2000;31:3008-3014.
  19. Jasperse B, Jakobs C, Eikelenboom MJ, Dijkstra CD, Uitdehaag BM, Barkhof F, Polman CH, Teunissen CE. N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gaschromatography-mass spectrometry. J Neurol. 2007;254:631-637. https://doi.org/10.1007/s00415-006-0415-5
  20. Barkovich AJ, Baranski K, Vigneron D, Partridge JC, Hallam DK, Hajnal BL, Ferriero DM. Proton MR spectroscopy for the evaluation of brain injury in asphyxiated, term neonates. AJNR Am J Neuroradiol. 1999;20:1399-1405. http://www.ajnr.org/content/ajnr/20/8/1399.full.pdf
  21. Cappellini M, Rapisardi G, Cioni ML, Fonda C. Acute hypoxic encephalopathy in the full-term newborn: correlation between Magnetic Resonance Spectroscopy and neurological evaluation at short and long term. Radiol Med (Torino). 2002;104:332-340. http://www.ajnr.org/content/23/3/371
  22. Jung RE, Haier RJ, Yeo RA, Rowland LM, Petropoulos H, Levine AS, Sibbitt WL, Brooks WM. Sex differences in N-acetylaspartate correlates of general intelligence: an 1H-MRS study of normal human brain. Neuroimage. 2005;26:965-972. https://doi.org/10.1016/j.neuroimage.2005.02.039
  23. Haier RJ. Neuro-intelligence, neuro-metrics and the next phase of brain imaging studies. Intelligence. 2009;37:121-123. https://doi.org/10.1016/j.intell.2008.12.006
  24. Bajmeeva NV, Miroshnichenko II. N-acetylaspartate is a biomarker of neuropsychiatric disorders in the brain (review). Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2015;115(8):54-58. (In Russ.) https://doi.org/10.17116/jnevro20151158194-98
  25. Gan JL, Cheng ZX, Duan HF, Yang JM, Xi-Quan Zhu, Cun You Gao. Atypical antipsychotic drug treatment for 6 months restores N-acetylaspartate in left prefrontal cortex and left thalamus of first-episode patients with early onset schizophrenia: A magnetic resonance spectroscopy study. Psychiatry Research: Neuroimaging. 2014. https://doi.org/10.1016/j.pscychresns.2014.04.010
  26. Patel T, Blyth JC, Griffiths G, Kelly D and Talcott JB (2014) Moderate relationships between NAA and cognitive ability in healthy adults: implications for cognitive spectroscopy. Front Hum Neurosci. 8:39. https://doi.org/10.3389/fnhum.2014.00039
  27. Long PM, Moffett JR, Namboodiri AMA, Viapiano MS, Lawler SE, Jaworski DM. N-Acetylaspartate (NAA) and N-Acetylaspartylglutamate (NAAG) Promote Growth and Inhibit Differentiation of Glioma Stem-like Cells. Journal of Biological Chemistry. 2013;288(36):26188-26200. https://doi.org/10.1074/jbc.M113.487553
  28. Napso EV. Pharmacology of Acetylaminosuccinic acid. Mezhdunarodnyj Zhurnal Prikladnyh i Fundamental’nyh Issledovanij. 2014;1:115-116. (In Russ.) URL: https://applied-research.ru/ru/article/view?id=4599
  29. Biohimiya mozga. Pod red. Oshmarina I.P., Stukalova P., Eshchenko N.D. SPb.: SPb universitet; 1999. (In Russ.)
  30. Zozulya IS, Martynyuk B, Majstruk OA. Nejroprotektory, nootropy, nejrometabolity v intensivnoj terapii porazhenij nervnoj sistemy. K.: Intermed; 2005. (In Russ.)
  31. Studenikin VM, Balkanskaya SV, Shelkovskiy VI. On application of acetylaminosiccine acid in neuropediatrics. Current Pediatrics. 2008;7(3):91-94. (In Russ.) https://vsp.spr-journal.ru/jour/article/view/1404
  32. Barashnev YuI. Perinatal’naya nevrologiya. M.: Triada-H; 2001. (In Russ.)
  33. Skoromec AP, Kryukova IA, Semichova IL, Shumilina MV, Fomina TV. Delays of mental development in children and principles of their correction. Lechashchij Vrach. 2011;5/11. (In Russ.) http://www.lvrach.ru/2011/05/ 15435193/
  34. Pivovarova AM. Asthenic states in children and teenagers. Prevention and treatment. Praktika pediatra. 2012;56-61. (In Russ.) https://medi.ru/info/8641/
  35. Kotova OV, Akarachkova ES. Asthenic syndrome in practice of the neurologist and the family doctor. RMZH. 2016;13:824-829. (In Russ.) https://www.rmj.ru/articles/nevrologiya/Astenicheskiy_sindrom_v_praktike_nevrologa_i_semeynogo_vracha/#ixzz5lMLpTcZW
  36. Grigor’ev KI, Povazhnaya EL, Solov’eva AL. Syndrome of vegetative dystonia at children and teenagers. Medicinskaya Sestra. 2013;7:28-32. (In Russ.) https://medsestrajournal.ru/system/files/medsestra-2013-07-05.pdf
  37. Onegin EV, Onegina OE. The basic principles of treatment of epilepsy at children. Zhurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta. 2007;3(19):100-105. (In Russ.). http://journal-grsmu.by/index.php/ojs/article/view/1359/1270
  38. Milovanova OA, Astanina SYu. Treatment of asthenoneurotic disorders in children. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2016;116(12):112-113. (In Russ.) https://doi.org/10.17116/jnevro2016116121112-113
  39. Djukova GM. Asthenic syndrome: problems of diagnostics and therapy. Jeffektivnaja farmakoterapija. Nevrologija i Psihiatrija. 2012;1:16-22. (In Russ.)
  40. Zavadenko NN. Giperaktivnost’ i deficit vnimaniya v detskom vozraste. Uchebnoe posobie dlya vuzov. Seriya: Avtorskij uchebnik. 2-e izd., pererab. i dop. M.: Yurajt; 2018. (In Russ.). https://urait.ru/uploads/pdf_review/A76055 C2-EE74-43B4-82D8-4178BB867654.pdf
  41. Lapochkin OL. Zatratnaya effektivnost’ primeneniya lekarstvennoj terapii pri sindrome deficita vnimaniya s giperaktivnost’yu. Medicinskie tekhnologii. Ocenka i Vybor. 2014;4(18):60-63. (In Russ.)
  42. Simashkova NV. Effective pharmacotherapy and rehabilitation of patients with autism spectrum disorders. Nevrologiya i Psihiatriya. 2011;3:14-22. (In Russ.). https://medi.ru/info/1072/
  43. Koval’-Zajcev AA, Zvereva NV, Simashkova NV. Application of the psikhologoobrazovatelny y test for psychological qualification of severity of state in early onset schizophrenia. Voprosy psikhicheskogo zdorov'ya detey i podrostkov. 2007;1:82-90. (In Russ.) http://www.acpp.ru/data/materials/jornal/2007-1.pdf
  44. Kozlova IA, Goryunov AV, Koval’-Zajcev AV. Experience of using Cerebrolysin in the complex therapy of child schizophrenia out of exacerbation. Psihiatriya. 2009;2:25-30. (In Russ.) http://ncpz.ru/stat/196
  45. Signoretti S, Vagnozzi R, Tavazzi B, Lazzarino G. Biochemical and neurochemical sequelae following mild traumatic brain injury: summary of experimental data and clinical implications. Neurosurg Focus. 2010;29:E1. https://doi.org/10.3171/2010.9.FOCUS10183
  46. Filippi CG, Uluğ AM, Deck MD, Zimmerman RD, Heier LA. Developmental Delay in Children: Assessment with Proton MR Spectroscopy. American Journal of Neuroradiology. 2002;23(5):882-888. http://www.ajnr.org/content/23/5/882.long
  47. Suhotina NK, Egorova TI. Ocenochnye shkaly sindroma deficita vnimaniya s giperaktivnost’yu (SDVG). Social’naya i Klinicheskaya Psihiatriya. 2008;18(4):15-21. (In Russ.) https://cyberleninka.ru/article/n/otsenochnye-shkaly-sindroma-defitsita-vnimaniya-s-giperaktivnostyu
  48. Wood SJ, Berger GE, Lambert M, Conus P, Velakoulis D, Stuart GW, Desmond P, McGorry PD, Pantelis C. Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry. 2006;63:969-976. https://doi.org/10.1001/archpsyc.63.9.969
  49. Jessen F, Scherk H, Traber F, Theyson S, Berning J, Tepest R, Falkai P, Schild HH, Maier W, Wagner M, Block W. Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia. Schizophr Res. 2006;87:81-88. https://doi.org/10.1016/j.schres.2006.06.011
  50. Ohrmann P, Siegmund A, Suslow T, Spitzberg K, Kersting A, Arolt V, Heindel W, Pfleiderer B. Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study. Schizophr Res. 2005;73:153-157. https://doi.org/10.1016/j.schres.2004.08.021
  51. Jessen F, Fingerhut N, Sprinkart AM. N-acetylaspartylglutamate (NAAG) and N-acetylaspartate (NAA) in patients with schizophrenia. Schizophrenia Bulletin. 2013;39(1):197-205. https://doi.org/10.1093/schbul/sbr127
  52. Ledda MG, Fratta AL, Pintor M, Zuddas A, Cianhetti C. Early onset Psychoses: Comparison of Clinical Features and Adult Outcome in 3 Diagnostic Groups. Child Psychiatry Human Development. 2009;40:3:421-437.
  53. Kobzova MP, Zvereva NV, Goryunov AV, Shchelokova OA, Simonov VN. Cognitive functions, social functioning and self-esteem in young male patients with adolescence onset schizotypal disorder. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2013;113(11):17-21. (In Russ.)
  54. Goryunova AV, Danilova LYu, Goryunov AV. Characteristics of neurological status in children with schizophrenia and schizotypal disorder. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova («Detskaya Nevrologiya i Psihiatriya». 2015;115:5(2):14-20. (In Russ.) https://doi.org/10.17116/jnevro20151155214-20
  55. Smulevich AB, Kharkova GS, Lobanova VM, Voronova EI. Asthenia in the psychopathological space of schizophrenia and schizophrenia spectrum disorders (The concept of asthenic deficit in aspect of the modern model of negative symptoms). Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2019;119(5):7-14. (In Russ.) https://doi.org/10.17116/jnevro20191190517
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.